Advertisement

Nano-Based Drug Delivery Tools for Personalized Nanomedicine

  • Shama Parveen
  • Neera Yadav
  • Monisha Banerjee
Chapter
  • 96 Downloads
Part of the Nanotechnology in the Life Sciences book series (NALIS)

Abstract

Nanobiotechnology is a branch of science where nanodevices are developed through nanotechnology and are applied to study the biological system. The word “nano” is used for measurement of things on a nanoscale, and the technology thereof used for formation of such compounds is known as “nanotechnology.” Nanomaterials range approximately from 1 to 100 nm. It is an exciting area for researchers as it is applied in different biological fields like reengineered medicine, medical reports, and drug delivery systems. Nanotechnology has allowed humans to gain in-depth information about materials to create, control, manipulate, characterize, and engineer nanomaterials. It provides an unrivaled platform to improve the treatment of diseases. These nanotools can act as probes, sensors, or vehicles for delivery of compounds, drugs, and biomolecules into the cell. Personalized nanomedicine consists of treatment strategies where specific treatment is advised to patients according to their genotype, phenotype, and environmental conditions.

Keywords

Nanoparticles Drug delivery Nanodrugs Nanovaccines Diagnostics 

Notes

Acknowledgments

SP and NY are thankful to Council of Scientific and Industrial Research (CSIR) and University Grants Commission (UGC), New Delhi, respectively, for providing financial assistance. The research grant provided to Molecular and Human Genetics Lab by Higher Education, Govt. of UP, Lucknow, under Centre of Excellence program is duly acknowledged.

References

  1. Arya G, Das M, Sahoo SK (2018) Evaluation of curcumin loaded chitosan/PEG blended PLGA nanoparticles for effective treatment of pancreatic cancer. Biomed Pharmacother 102:555–566CrossRefGoogle Scholar
  2. Cevc G, Vierl U (2010) Nanotechnology and the transdermal route: a state of the art review and critical appraisal. J Control Release 141(3):277–299CrossRefGoogle Scholar
  3. Chen P, Chung MT, McHugh W, Nidetz R, Li Y, Fu J et al (2015) Multiplex serum cytokine immunoassay using nanoplasmonic biosensor microarrays. ACS Nano 9(4):4173–4181CrossRefGoogle Scholar
  4. Dai L, Zhu W, Si C, Lei J (2018) “Nano-ginseng” for enhanced cytotoxicity against cancer cells. Int J Mol Sci 19(2):627CrossRefGoogle Scholar
  5. Dian L, Yu E, Chen X, Wen X, Zhang Z, Qin L, Wu C (2014) Enhancing oral bioavailability of quercetin using novel soluplus polymeric micelles. Nanoscale Res Lett 9(1):684CrossRefGoogle Scholar
  6. Dodd CH, Hsu HC, Chu WJ, Yang P, Zhang HG, Mountz JD Jr et al (2001) Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HIV transactivator-peptide-derived super paramagnetic nanoparticles. J Immunol Methods 256(1–2):89–105CrossRefGoogle Scholar
  7. Duan L, Wang Y, Li SSC, Wan Z, Zhai J (2005) Rapid and simultaneous detection of human hepatitis B virus and hepatitis C virus antibodies based on a protein chip assay using nano-gold immunological amplification and silver staining method. BMC Infect Dis 5(1):53CrossRefGoogle Scholar
  8. Englander L, Friedman A (2010) Nitric oxide nanoparticle technology: a novel antimicrobial agent in the context of current treatment of skin and soft tissue infection. J Clin Aesthet Dermatol 3(6):45PubMedPubMedCentralGoogle Scholar
  9. Fornaguera C, García-Celma MJ (2017) Personalized nanomedicine: a revolution at the nanoscale. J Pers Med 7(4):12CrossRefGoogle Scholar
  10. Ge Y, Li S, Wang S, Moore R (eds) (2014) Nanomedicine: Principles and Perspectives. Springer, New YorkGoogle Scholar
  11. Hanaee H, Ghourchian H, Ziaee AA (2007) Nanoparticle-based electrochemical detection of hepatitis B virus using stripping chronopotentiometry. Anal Biochem 370(2):195–200CrossRefGoogle Scholar
  12. Kansara K, Patel P, Shukla RK, Pandya A, Shanker R, Kumar A, Dhawan A (2018) Synthesis of biocompatible iron oxide nanoparticles as a drug delivery vehicle. Int J Nanomedicine 13:79CrossRefGoogle Scholar
  13. Ladju RB, Pascut D, Massi MN, Tiribelli C, Sukowati CH (2018) Aptamer: a potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma. Oncotarget 9(2):2951CrossRefGoogle Scholar
  14. Lee JH, Seo HS, Kwon JH, Kim HT, Kwon KC, Sim SJ et al (2015) Multiplex diagnosis of viral infectious diseases (AIDS, hepatitis C, and hepatitis A) based on point of care lateral flow assay using engineered proteinticles. Biosens Bioelectron 69:213–225CrossRefGoogle Scholar
  15. Liu Y, Li L, Li L, Zhou Z, Wang F, Xiong X, Huang Y (2018) Programmed drug delivery system based on optimized “size decrease and hydrophilicity/hydrophobicity transformation” for enhanced hepatocellular carcinoma therapy of doxorubicin. Nanomedicine 14(4):1111–1122CrossRefGoogle Scholar
  16. Mahajan SD, Aalinkeel R, Law WC, Reynolds JL, Nair BB, Sykes DE et al (2012) Anti-HIV-1 nanotherapeutics: promises and challenges for the future. Int J Nanomedicine 7:5301CrossRefGoogle Scholar
  17. Nelson CE, Kim AJ, Adolph EJ, Gupta MK, Yu F, Hocking KM et al (2014) Tunable delivery of siRNA from a biodegradable scaffold to promote angiogenesis in vivo. Adv Mater 26(4):607–614CrossRefGoogle Scholar
  18. Popov AP, Zvyagin AV, Lademann J, Roberts MS, Sanchez W, Priezzhev AV, Myllylä R (2010) Designing inorganic light-protective skin nanotechnology products. J Biomed Nanotechnol 6(5):432–451CrossRefGoogle Scholar
  19. Romeo A, Leung TS, Sanchez S (2016) Smart biosensors for multiplexed and fully integrated point-of-care diagnostics. Lab Chip 16(11):1957–1961CrossRefGoogle Scholar
  20. Sadzuka Y, Kishi K, Hirota S, Sonobe T (2003) Effect of polyethyleneglycol (PEG) chain on cell uptake of PEG-modified liposomes. J Liposome Res 13(2):157–172CrossRefGoogle Scholar
  21. Saw PE, Yu M, Choi M, Lee E, Jon S, Farokhzad OC (2017) Hyper-cell-permeable micelles as a drug delivery carrier for effective cancer therapy. Biomaterials 123:118–126CrossRefGoogle Scholar
  22. Shingadia D, Novelli V (2003) Diagnosis and treatment of tuberculosis in children. Lancet Infect Dis 3(10):624–632CrossRefGoogle Scholar
  23. Song Y, Zhang Y, Bernard PE, Reuben JM, Ueno NT, Arlinghaus RB et al (2012) Multiplexed volumetric bar-chart chip for point-of-care diagnostics. Nat Commun 3:1283CrossRefGoogle Scholar
  24. Tang DP, Yuan R, Chai YQ, Zhong X, Liu Y, Dai JY, Zhang LY (2004) Novel potentiometric immunosensor for hepatitis B surface antigen using a gold nanoparticle-based biomolecular immobilization method. Anal Biochem 333(2):345–350CrossRefGoogle Scholar
  25. Tran N, Webster TJ (2009) Nanotechnology for bone materials. Wiley Interdiscip Rev Nanomed Nanobiotechnol 1(3):336–351CrossRefGoogle Scholar
  26. Vallianou NG, Evangelopoulos A, Schizas N, Kazazis C (2015) Potential anticancer properties and mechanisms of action of curcumin. Anticancer Res 35(2):645–651PubMedGoogle Scholar
  27. Veigas B, Machado D, Perdigao J, Portugal I, Couto I, Viveiros M, Baptista PV (2010) Au-nanoprobes for detection of SNPs associated with antibiotic resistance in Mycobacterium tuberculosis. Nanotechnology 21(41):415101CrossRefGoogle Scholar
  28. Verma D, Gulati N, Kaul S, Mukherjee S, Nagaich U (2018) Protein based nanostructures for drug delivery. J Pharm 2018:9285854.  https://doi.org/10.1155/2018/9285854CrossRefGoogle Scholar
  29. Wang Q, Zhang N, Hu X, Yang J, Du Y (2008) Chitosan/polyethylene glycol blend fibers and their properties for drug controlled release. J Biomed Mater Res A 85(4):881–887CrossRefGoogle Scholar
  30. Wang S, Inci F, De Libero G, Singhal A, Demirci U (2013) Point-of-care assays for tuberculosis: role of nanotechnology/microfluidics. Biotechnol Adv 31(4):438–449CrossRefGoogle Scholar
  31. World Health Organization (2010) Global tuberculosis control: WHO report 2010. World Health Organization, GenevaGoogle Scholar
  32. Yang R, Xu J, Xu L, Sun X, Chen Q, Zhao Y et al (2018) Cancer cell membrane-coated adjuvant nanoparticles with mannose modification for effective anticancer vaccination. ACS Nano 12(6):5121–5129CrossRefGoogle Scholar
  33. Zhang XQ, Xu X, Bertrand N, Pridgen E, Swami A, Farokhzad OC (2012) Interactions of nanomaterials and biological systems: implications to personalized nanomedicine. Adv Drug Deliv Rev 64(13):1363–1384CrossRefGoogle Scholar
  34. Zhang P, An K, Duan X, Xu H, Li F, Xu F (2018) Recent advances in siRNA delivery for cancer therapy using smart nanocarriers. Drug Discov Today 23(4):900–911CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Shama Parveen
    • 1
  • Neera Yadav
    • 1
  • Monisha Banerjee
    • 1
  1. 1.Molecular & Human Genetics Laboratory, Department of ZoologyUniversity of LucknowLucknowIndia

Personalised recommendations